• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Gastroenterology

Microbiota-directed food intervention showed benefits for undernourished children

byNhat Hung (Benjamin) LamandHarsh Shah
April 27, 2021
in Gastroenterology, Pediatrics, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. A microbiota-directed complimentary food showed growth and developmental improvements for undernourished children compared to conventional ready-to-use supplementary food.

2. The improved outcomes were linked to the gut bacterial taxa previously demonstrated to correlate with healthy childhood development.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Childhood undernourishment remains a global health challenge with stunting growth and long-term sequelae in cognition, immunity, and metabolism. Conventional food interventions, without focusing on the microbiota, have shown limited success in treating malnourished children. As such, this study aimed at comparing the effects of twice-daily supplementation of microbiota-directed complimentary food prototype 2 (MDCF-2) and ready-to-use supplementary food (RUSF) on improving the growth of undernourished children. The study determined MDCF-2 provided superior improvements on weight-for-length and weight-for-age compared to RUSF. Furthermore, this difference was linked to changes in 70 plasma proteins and 21 bacterial taxa that have previously been associated with weight-for-length z-score. These proteins include markers of bone and nervous system development. The study was limited by not testing for composition through changes in fat mass and lean mass. Nonetheless, the study’s results are significant, as this study provided support for the microbiota-directed food supplementation as an efficacious therapy for childhood malnutrition.

Clicker to read the study in NEJM

Relevant Reading: Effects of microbiota-directed foods in gnotobiotic animals and undernourished children

RELATED REPORTS

Typhoid conjugate vaccine shows promising long-term efficacy in children

Atypical deglutition associated with obstructive sleep apnea in children

Wellness Check: Sleep

In-Depth [randomized controlled trial]: This randomized controlled trial enrolled 123 children in Mirpur, Bangladesh. Children between 12 and 18 months of age and had moderate acute malnutrition, defined by the World Health Organization as weight-for-length two to three standard deviations below the age cohort median, were included in the study. Children classified with chronic malnutrition were excluded from the study. The children were randomized in a 1:1 ratio to receive either MDCF-2 or RUSF, respectively. The primary outcomes were weight-for-length z score and weight-for-age z score. The study found MDCF-2 resulted in better outcomes in weight-for-length and weight-for-age z score improvements over the study period. Specifically, the between-group differences in mean weekly change were 0.011 in weight-for-length z score (95% confidence interval [CI], 0.001 to 0.021) and 0.008 in weight-for-age z score (95% CI, 0.001 to 0.015). Among the plasma proteins examined, more proteins were significantly altered by MDCF-2 (714 proteins) than RUSF (82 proteins). Specifically, the proteins significantly enriched in the MDCF-2 group relative to RUSF were associated with weight-for-length z scores (WLZ), musculoskeletal, and nervous systems development (P<0.001). On the other hand, pro-inflammatory markers, heightened by malnutrition at the beginning of the study, were reduced to a larger extent by MDCF-2 supplementation. Bacteria taxa positively associated with WLZ, such as Facecalibacterium prausnitzii, were significantly increased by MDCF-2 than RUSF (P<0.001). Conversely, the Bifidobacterium species, negatively associated with WLZ, were significantly reduced by MDCF-2 (P<0.001). Overall, this study highlighted the potential benefits of the MDCF-2 approach and identified key plasma and microbiota biomarkers underlying these improvements.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: childrenfood as medicinemicrobiotaundernutrition
Previous Post

Sacituzumab govitecan increased survival in metastatic triple-negative breast cancer

Next Post

Replacement of infusion sets every seven days may be safe and cost-effective to prevent life-threatening catheter-related bloodstream infections

RelatedReports

Preterm infants responsive to PCV13 vaccine
Infectious Disease

Typhoid conjugate vaccine shows promising long-term efficacy in children

March 26, 2024
Parents with poor sleep quality report sleep problems in kids
Psychiatry

Atypical deglutition associated with obstructive sleep apnea in children

March 15, 2024
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Wellness

Wellness Check: Sleep

March 14, 2024
Quick Take: Sugary drink consumption and risk of cancer: results from NutriNet-Santé prospective cohort
Lifestyle

Sugar-sweetened beverage intake may be associated with lower sleep duration in children

January 5, 2024
Next Post
Surgical site anesthetic infusion may enhance analgesia after mastectomy

Replacement of infusion sets every seven days may be safe and cost-effective to prevent life-threatening catheter-related bloodstream infections

#VisualAbstract: Aspirin treatment without indication in patients on direct oral anticoagulants may increase the risk of bleeding events

#VisualAbstract: Aspirin treatment without indication in patients on direct oral anticoagulants may increase the risk of bleeding events

Comprehensive geriatric assessment in primary care associated with reduced need for hospitalization in elderly

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss
  • Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
  • 2 Minute Medicine Rewind June 23, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.